Evolent Health inks deal to acquire IPG for $375M

Evolent Health this week announced an agreement to buy IPG, which develops technology and surgical management services for musculoskeletal conditions.

WHY IT MATTERS
The deal calls for Evolent to pay TPG Growth, the growth equity platform of alternative asset firm TPG, $375 million for the company – plus a potential additional consideration of up to $87 million, depending on certain benchmarks.

The acquisition is meant to expand Evolent’s…